Management of acute asthma exacerbation in adults | Medibuddy
5th January 2024

Management of acute asthma exacerbation in adults

Determining severity

The severity of asthma is graded as follows:

Moderate Acute severe Life-threatening Near-fatal
PEFR > 50-70 best or predicted
Normal speech
PEFR 33-50% best or predicted or
RR >= 25/min or
HR >= 110/min
Inability to complete sentences or
Accessory muscle use
SpO2 > 92%
In a patient with severe asthma with any of the following:
PEFR less than 33% or SpO2 <92% or
Altered consciousness or Confusion or
Exhaustion or Cardiac arrythmia or
Hypotension or Cyanosis or
Poor respiratory effort or Silent chest or
Poor respiratory effort
Raised Carbon dioxide partial pressure or
Requiring mechanical ventilation

Table1. Asthma severity classification

SIGN Asthma Guideline Quick Reference Guide 2019 [Internet]. British Thoracic Society; 2019. Available from: https://www.brit-thoracic.org.uk/document-library/guidelines/asthma/btssign-asthma-guideline-quick-reference-guide-2019/

Assess the need for hospital admission

All patients with life-threatening asthma should be admitted to hospital. All patients with features of severe asthma persisting after initial bronchodilator therapy should be admitted. Patients with moderate asthma with worsening symptoms after initial treatment, or those who have had previous life-threatening attacks should be admitted.

Treatment of acute asthma

  • Maintain a saturation of 94-98% with supplemental oxygen if required
  • Beta 2 agonist bronchodilator (Salbutamol) via nebuliser. In patients with acute severe or life-threatening asthma, nebuliser should be oxygen-driven. Use intravenous Beta 2 agonist if inhaled therapy cannot be used reliably.
  • Nebulised Ipratropium bromide (0.5 mg 4-6 hourly) for acute severe or life-threatening exacerbation or for those with inadequate response to initial Beta 2 agonist.
  • Steroid to all patients with asthma exacerbation. Continue with prednisolone (40-50 mg daily) until recovery or minimum of 5 days.
  • Single dose of intravenous magnesium sulphate (1.2-2 g infusion over 20 minutes) can be given in acute severe or life-threatening asthma who have had inadequate response to initial bronchodilators.
  • Antibiotics should only be given in case of bacterial infection.

Any patient with one of the following features should be referred to critical care:

  • Any patient who is requiring ventilatory support.
  • Patients with severe or life-threatening asthma who fail to respond to therapy as:
    • Worsening PEF
    • Worsening hypoxia
    • Hypercapnia
    • Acidosis on ABG
    • Exhaustion
    • Respiratory arrest
    • Confusion or altered consciousness
Mobile app screenshots

Take your subscriptions with you

Our mobile app allows you to access your interview and exam question banks wherever you are.